provider
Search result for "Solr search content"
Search Result for "Breast Cancer"
provider
Federico Tozzi, MD Surgical Oncology, Surgery
Clinical Trial
A Multicenter Phase 1 Study to Determine the Maximum Tolerated Dose/ Maximum Feasible Dose, Safety, and Efficacy of Single Dose Rhenium-186 NanoLiposome (186RNL) Administered via Intraventricular Catheter for Leptomeningeal Metastases (CTMS# 21-0138)
This is an open-label, multicenter, Phase 1 dose-escalation study to establish the safety and tolerability of a single dose of 186RNL by the intraventricular route (via intraventricular catheter) and to identify a maximum tolerated dose (MTD) and/or maximum feasible dose (MFD).
Our Community Outreach and Engagement Impact
Our Community Outreach and Engagement Impact
provider
William Kelly, M.D. Neuro-Oncology, Hematology Oncology
Cardio-Oncology Program
Cardio-Oncology Program
Gynecologic Oncology Program
Gynecologic Oncology Program
COE Community Advisory Board
COE Community Advisory Board